We are on the cusp of a new era. With net zero hurtling up the agenda, our industry must view decarbonisation as a wider company strategy.
With this in mind, I will draw from NIRAS’ new report, to explain how pharmaceutical businesses can plan effectively for the future.
As global efforts to reduce the climate emergency intensify, the pharmaceutical and life sciences industries, like all sectors, are under increasing pressure to reduce their greenhouse gas emissions.
Check out the rest of the feature here
